2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer (Q27002509)

ORCID Public Data File 2021

author name string

W. E. E. Eberhardt

1

1 reference

D. De Ruysscher

2

1 reference

W. Weder

3

1 reference

C. Le Péchoux

4

1 reference

P. De Leyn

5

1 reference

H. Hoffmann

6

1 reference

V. Westeel

7

1 reference

R. Stahel

8

1 reference

E. Felip

9

1 reference

S. Peters

10

1 reference

language of work or name

1 reference

August 2015

1 reference

1 reference

26

1 reference

PubMed

issue

8

1 reference

PubMed

page(s)

1573-88

1 reference

Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Preoperative staging of lung cancer with combined PET-CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Survival after trimodality treatment for superior sulcus and central T4 non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Sleeve lobectomy versus pneumonectomy for non-small cell lung cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Complete resection in lung cancer surgery: proposed definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Management of Pancoast tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: A systematic review and metaanalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Combined endobronchial and endoscopic ultrasound-guided fine needle aspiration for mediastinal lymph node staging of lung cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Screening of brain metastasis with limited magnetic resonance imaging (MRI): clinical implications of using limited brain MRI during initial staging for non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Use of normal tissue complication probability models in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Radiation dose-volume effects in the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Role of Postoperative Radiotherapy in Resected Non-Small Cell Lung Cancer: A Reassessment Based on New Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a mult

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Neoadjuvant Chemoradiation for Clinically Advanced Non-Small Cell Lung Cancer: An Analysis of 233 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Stage IIIA non-small cell lung cancer: morbidity and mortality of three distinct multimodality regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Effectiveness and toxicity of preoperative therapy in stage IIIA non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky mediastinal lymph node metastases (Clinical N2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Sleeve pneumonectomy for central non-small cell lung cancer: indications, complications, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 S

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Randomized phase II trial of non-platinum induction or consolidation chemotherapy plus concomitant chemoradiation in stage III NSCLC patients: mature results of the Spanish Lung Cancer Group 0008 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Non-small cell lung tumors repopulate rapidly during radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Improving radiation conformality in the treatment of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Variability in the treatment of elderly patients with stage IIIA (N2) non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer].

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187

Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDV187